Frequently Asked Questions
The market is segmented based on Global Haemorrhoids Treatment Market, By Type (Internal Haemorrhoids and External Haemorrhoids), Treatment (Medication, Devices, and Surgery), Drugs (Topical Steroids, Topical Anaesthetics, and Others), Devices (Cryotherapy Devices, Haemorrhoid Laser Probes, and Others), Route of Administration (Oral, Topical, and Others), End Users (Hospitals, Homecare, Specialty Clinics, and Others) - Industry Trends and Forecast to 2030.
.
The Global Hemorrhoids Treatment Market size was valued at USD 730.20 USD Million in 2022.
The Global Hemorrhoids Treatment Market is projected to grow at a CAGR of 11.88% during the forecast period of 2023 to 2030.
The major players operating in the market include Pfizer , Johnson & Johnson Services , GlaxoSmithKline plc, F. Hoffmann La Roche Ltd, Novartis AG, AstraZeneca, Eli Lilly and Company, Abbott, Merck & Co , AbbVie , Allergan, Teva Pharmaceutical Industries Ltd, Takeda Pharmaceutical Company Limited, Bristol Myers Squibb Company, Medtronic, Bayer AG, Olympus Corporation, Lupin Pharmaceuticals , Boehringer Ingelheim International GmbH.
The market report covers data from the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
